🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07739069
Starting soon Not applicable

Action Observation Versus Mirror Therapy in Children With Spastic Hemiplegic Cerebral Palsy

NCT07739069 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-08-01
Last updated
2026-07-31

Condition(s) studied

Hemiplegic Cerebral Palsy

Investigational drug(s) / intervention(s)

Mirror TherapyAction Observation Therapy

Mirror Therapy: Participants will receive 45-minute mirror therapy sessions in addition to the traditional physical therapy program, three sessions per week for 12 consecutive weeks. During mirror therapy, the child will be seated with a mirror positioned in the midsagittal plane to reflect movements of the unaffected upper limb while concealing the affected upper limb, creating the visual illusion of normal movement in the affected limb. Children will observe the reflected movements while simultaneously attempting to perform the same functional tasks with the affected upper limb. The intervention includes task-oriented upper extremity activities such as object transfer, grasp and release, coin placement, ball gripping, card turning, circle drawing, block building, and water pouring.

Action Observation Therapy: Participants will receive 45-minute action observation therapy sessions in addition to the traditional physical therapy program, three sessions per week for 12 consecutive weeks. During each session, children will observe videos demonstrating goal-directed upper extremity activities matched to their functional level, followed by performance of the same activities using the affected upper limb under therapist supervision. The intervention includes task-oriented activities such as block transfer, line drawing, card turning, coin placement, cup stacking, ball squeezing, water pouring and drinking, and moving beverage cans. Video demonstrations are presented from multiple viewing angles to facilitate motor learning and action observation.

Study summary

The goal of this clinical trial is to compare the effects of Action Observation therapy and Mirror therapy on hand grip strength and upper extremity function in children with hemiplegic cerebral palsy.

Participants will be randomly assigned into two study groups of equal numbers:

A group will receive traditional physical therapy program followed by mirror therapy protocol 3 times/ week for 12 weeks.

Another group will receive the same traditional physical therapy program in addition exercises using action observation therapy, 3 times/week for 12 weeks.

Then, the effect of both treatments will be compared between the two groups.

Eligibility

Sex
ALL
Min age
5 Years
Max age
10 Years
Healthy volunteers
No
Inclusion Criteria: * 1- Children diagnosed with spastic hemiplegic CP. 2- Their ages between 5-10 years. 3- Lack of use of the affected upper limb. 4- They will be at level II-III of the Manual Ability Classification System (MACS) 5- The will be at level I-II in the Gross Motor Function Classification System (GMFCS) 6- They will be graded 1 to 1+ in the affected U.L. on Modified Ashworth's Scale 7- The children should be capable of understanding and following instructions. Exclusion Criteria: 1. The children will be excluded if they have one of the following: 2. Children with fixed contracture in the affected U.L. 3. Injection of botulinum toxin into the upper limb muscles during the previous 6 months. 4. Visual or Auditory disorders. 5. Upper limb surgery in the last one year. 6. Epilepsy.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
outpatient clinic of Faculty of Physical Therapy, Cairo University & outpatient clinic of Faculty of Physical Therapy, Misr University for Science and Technology, Egypt Giza Egypt

More Cairo University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07739069 on ClinicalTrials.gov ↗ ← All trials in Egypt